High density of TCF1+ stem-like tumor-infiltrating lymphocytes is associated with favorable disease-specific survival in NSCLC
Overall, these findings suggest that assessment of CD8+, PD1+, TCF1+ could serve as a potential prognostic biomarker in NSCLC.
Authors
- Ilona Urbárová (ORCID: https://orcid.org/0000-0001-6626-2917)
- Tom Dønnem
- Dagny Førde
- Sigve Andersen (ORCID: https://orcid.org/0000-0002-2402-570X)
- Erna‐Elise Paulsen (ORCID: https://orcid.org/0000-0002-6907-1224)
- Mehrdad Rakaee (ORCID: https://orcid.org/0000-0002-9080-0153)
- Thomas K. Kilvær (ORCID: https://orcid.org/0000-0003-1669-0117)
- Egil Støre Blix (ORCID: https://orcid.org/0000-0001-7372-6767)
- Mona Irene Pedersen
- Lill-Tove Rasmussen Busund
Institutions
- Oslo University Hospital (NO)
- University Hospital of North Norway (NO)
- UiT The Arctic University of Norway (NO)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-12-19
- DOI
- https://doi.org/10.3389/fimmu.2024.1504220
- Citations
- 3
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.85
Funders
- Universitetet i Tromsø
- Kreftforeningen
- Helse Nord RHF